TOVX Theriva Biologics Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik therivabio.com (TOVX)

Theriva Biologics, Inc. (TOVX) conducts proprietary clinical trials of oncolytic viruses, limiting its partnerships to research centers. Such alliances create scientific synergy, enhancing the attractiveness of assets for future M&A transactions. The firm's revenues are based on grants aimed at developing treatments for solid tumors. The business valuation relative to revenue illustrates fundamental stability, where the 1566.67 indicator determines the magnitude of the metric.

Nilai perusahaan marang pendapatan: Theriva Biologics Inc (TOVX) kanggo 23.11.2025 - 21.11.2026

therivabio.com - rincian analitis lan metrik utama (TOVX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Theriva Biologics, Inc. TOVX
Sampel barang Theriva Biologics, Inc.

Valuing Theriva Biologics, Inc. (TOVX) using the EV/Revenue multiple allows for the determination of the business's market price accounting for net debt, thereby eliminating the impact of capital structure on fundamental value. By analyzing EV/Sales dynamics, an investor can gauge the extent of asset overvaluation given the company's critical dependence on clinical trial outcomes and liquidity shortage risks within the highly competitive oncopharmaceuticals sector.

Analisis pesaing Theriva Biologics, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Sensei Biotherapeutics Inc SNSE|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP